Table 1 Demographics and participant characteristics by IAC injection type
TA N = 34 with 124 injections | TH N = 14 with 41 injections | p value | |
|---|---|---|---|
Relapse time in months (median [IQR]) | 3.00 [2.00, 6.00] | 11.00 [5.00, 18.00] | < 0.001* |
Age in years (median [IQR]) | 4.88 [2.92, 10.65] | 4.83 [3.02, 7.67] | 0.901 |
JIA disease duration in years (median [IQR]) | 0.46 [0.19, 2.66] | 1.17 [0.44, 4.33] | 0.179 |
Female (%) | 27 (79.4) | 10 (71.4) | 0.708 |
Ethnicity (%) | 0.160 | ||
White | 27 (79.4) | 13 (92.9) | |
Black | 4 (11.8) | 0 (0.0) | |
Hispanic | 3 (8.8) | 0 (0.0) | |
Unknown | 0 (0.0) | 1 (7.1) | |
JIA diagnosis (%) | 0.461 | ||
Oligo | 24 (70.6) | 12 (85.7) | |
Poly | 8 (23.5) | 1 (7.1) | |
Psoriatic | 2 (5.9) | 1 (7.1) | |
Injections by joint locations (%) | 0.051 | ||
Knee | 62 (50.0) | 24 (58.5) | |
Ankle | 31 (25.0) | 5 (12.2) | |
Wrist | 14 (11.3) | 1 (2.4) | |
Elbow | 2 (1.6) | 1 (2.4) | |
Fingers/toes | 14 (11.3) | 9 (22.0) | |
Hip | 1 (0.8) | 0 (0.0) | |
Mid-foot | 0 (0.0) | 1 (2.4) |